Andor Health, the leading AI-native clinical services company, announced it has received Frost & Sullivan's 2026 Competitive Strategy Leadership Recognition for North American Agentic AI-Based Care Orchestration. The recognition follows Andor Health's 2025 Frost & Sullivan recognition for Transformational Innovation Leadership in acute care virtual health.
Frost & Sullivan recognized Andor Health for its differentiated approach to healthcare transformation, combining agentic AI, intelligent workflow orchestration, and AI-native clinical services to drive measurable clinical and operational outcomes at enterprise scale. The analysis also highlighted Andor Health's interoperability-first strategy, rigorous AI governance, customer collaboration, and independently validated results.
"A key element of Andor Health's competitive strategy centers on maintaining technology independence across its agentic AI platform. Rather than relying on a single large language model or cloud provider, the company developed a patent-pending architecture that dynamically selects the most appropriate AI model for each clinical task," said Nitin Manocha, Senior Industry Analyst, Frost & Sullivan.
"Healthcare does not need more disconnected AI tools. Health systems need AI that can operate across the care continuum and take accountability for measurable outcomes," said Raj Toleti, CEO of Andor Health. "This recognition reflects the evolution of Andor Health from delivering AI infrastructure to delivering AI-native clinical services that combine intelligent automation with clinical expertise. Our focus is simple, to expand clinical capacity, improve outcomes, and own the outcome alongside our health system partners."